国药股份: 国药股份第八届董事会第二十五次会议决议公告

Group 1 - The board of directors of China National Pharmaceutical Group Corporation (referred to as "the company" or "China National Pharmaceutical") held its 25th meeting of the 8th board on June 2025, with all five directors present, including four independent directors [1][2] - The board unanimously approved the nomination of Liu Yuetao and Zhou Bin as candidates for the 8th board of directors, pending approval at the company's first extraordinary general meeting of shareholders in 2025 [1][2] - The board also approved the proposal for the party secretary Liu Yuetao to act as the general manager following the resignation of General Manager Tian Guotao due to work changes [2][3] Group 2 - The company will hold its first extraordinary general meeting of shareholders in 2025, with details disclosed on the Shanghai Stock Exchange website [2] - Liu Yuetao has held various positions within the company, including financial director and general manager, and has been the party secretary since June 2025 [2] - Both Liu Yuetao and Zhou Bin do not hold shares in the company and have no related party relationships with other directors, supervisors, senior management, or major shareholders [3][5]